Evaluation of drug metabolism
Home > Our Services > Pharmaceutical Contract R&D Service > Bioanalytic testing services > Evaluation of drug metabolism
According to the FDA guidance, safety evaluation shall be carried out when the content of human metabolites of a drug exceeds 10% of the total drug, but due to its chemical instability, biological activity, structural uncertainty, low content and lack of standard products, the qualitative and quantitative evaluation of metabolites is a challenge to analytical chemistry. Titanium Pharmaceutical have strong technical personnel in chemistry and suitable equipment.
The following related services are available for customers:
Drug metabolite identification/profile analysis
Metabolic pathway identification
Enzyme inhibition/induction assessment
Plasma protein binding
Metabolite bioanalysis
